Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 7 studies | 32% ± 21% | |
pancreatic A cell | 3 studies | 46% ± 4% | |
type B pancreatic cell | 3 studies | 67% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 95% | 453.43 | 20 / 21 | 97% | 9.49 | 490 / 504 |
brain | 93% | 5542.98 | 2450 / 2642 | 99% | 24.54 | 700 / 705 |
uterus | 96% | 595.09 | 163 / 170 | 95% | 8.57 | 436 / 459 |
intestine | 92% | 756.63 | 890 / 966 | 98% | 10.53 | 515 / 527 |
pancreas | 81% | 489.05 | 266 / 328 | 98% | 30.43 | 175 / 178 |
ovary | 77% | 321.37 | 138 / 180 | 99% | 7.96 | 427 / 430 |
lung | 79% | 376.16 | 458 / 578 | 96% | 11.03 | 1110 / 1155 |
prostate | 95% | 556.29 | 232 / 245 | 75% | 2.58 | 374 / 502 |
stomach | 75% | 382.09 | 269 / 359 | 92% | 8.22 | 264 / 286 |
esophagus | 68% | 424.03 | 989 / 1445 | 97% | 10.45 | 178 / 183 |
breast | 58% | 212.86 | 265 / 459 | 96% | 6.88 | 1070 / 1118 |
skin | 42% | 285.21 | 751 / 1809 | 92% | 7.00 | 432 / 472 |
thymus | 76% | 292.90 | 495 / 653 | 51% | 1.47 | 309 / 605 |
adrenal gland | 39% | 229.85 | 100 / 258 | 86% | 36.85 | 198 / 230 |
kidney | 58% | 227.73 | 52 / 89 | 44% | 1.85 | 397 / 901 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.13 | 1 / 1 |
blood vessel | 77% | 418.52 | 1028 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 73% | 2.20 | 58 / 80 |
tonsil | 0% | 0 | 0 / 0 | 71% | 3.15 | 32 / 45 |
spleen | 64% | 238.63 | 155 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 55% | 1.58 | 16 / 29 |
adipose | 47% | 165.31 | 562 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 43% | 232.03 | 398 / 929 | 0% | 0 | 0 / 0 |
liver | 9% | 30.01 | 21 / 226 | 26% | 1.79 | 107 / 406 |
muscle | 9% | 30.27 | 74 / 803 | 0% | 0 | 0 / 0 |
heart | 6% | 20.78 | 54 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016925 | Biological process | protein sumoylation |
GO_0050796 | Biological process | regulation of insulin secretion |
GO_0048488 | Biological process | synaptic vesicle endocytosis |
GO_0017156 | Biological process | calcium-ion regulated exocytosis |
GO_0006886 | Biological process | intracellular protein transport |
GO_0016079 | Biological process | synaptic vesicle exocytosis |
GO_2000463 | Biological process | positive regulation of excitatory postsynaptic potential |
GO_0032940 | Biological process | secretion by cell |
GO_0006887 | Biological process | exocytosis |
GO_0010807 | Biological process | regulation of synaptic vesicle priming |
GO_0010701 | Biological process | positive regulation of norepinephrine secretion |
GO_0048278 | Biological process | vesicle docking |
GO_0045956 | Biological process | positive regulation of calcium ion-dependent exocytosis |
GO_0033605 | Biological process | positive regulation of catecholamine secretion |
GO_0001956 | Biological process | positive regulation of neurotransmitter secretion |
GO_0030073 | Biological process | insulin secretion |
GO_0031629 | Biological process | synaptic vesicle fusion to presynaptic active zone membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0012505 | Cellular component | endomembrane system |
GO_0048787 | Cellular component | presynaptic active zone membrane |
GO_0030672 | Cellular component | synaptic vesicle membrane |
GO_0043005 | Cellular component | neuron projection |
GO_0005829 | Cellular component | cytosol |
GO_0008021 | Cellular component | synaptic vesicle |
GO_0070044 | Cellular component | synaptobrevin 2-SNAP-25-syntaxin-1a complex |
GO_0030424 | Cellular component | axon |
GO_0031965 | Cellular component | nuclear membrane |
GO_0008076 | Cellular component | voltage-gated potassium channel complex |
GO_0031201 | Cellular component | SNARE complex |
GO_0019900 | Molecular function | kinase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0000149 | Molecular function | SNARE binding |
GO_0019855 | Molecular function | calcium channel inhibitor activity |
GO_0005515 | Molecular function | protein binding |
GO_0005484 | Molecular function | SNAP receptor activity |
GO_0019869 | Molecular function | chloride channel inhibitor activity |
Gene name | STX1A |
Protein name | Syntaxin-1A (Neuron-specific antigen HPC-1) Syntaxin-1A |
Synonyms | STX1 hCG_96107 |
Description | FUNCTION: Plays an essential role in hormone and neurotransmitter calcium-dependent exocytosis and endocytosis . Part of the SNARE (Soluble NSF Attachment Receptor) complex composed of SNAP25, STX1A and VAMP2 which mediates the fusion of synaptic vesicles with the presynaptic plasma membrane. STX1A and SNAP25 are localized on the plasma membrane while VAMP2 resides in synaptic vesicles. The pairing of the three SNAREs from the N-terminal SNARE motifs to the C-terminal anchors leads to the formation of the SNARE complex, which brings membranes into close proximity and results in final fusion. Participates in the calcium-dependent regulation of acrosomal exocytosis in sperm . Also plays an important role in the exocytosis of hormones such as insulin or glucagon-like peptide 1 (GLP-1) (By similarity). . |
Accessions | X5D7S1 Q75ME0 Q16623 A0A0C4DFZ1 ENST00000395155.3 ENST00000395156.7 [Q16623-3] ENST00000222812.8 [Q16623-1] ENST00000395154.7 A8MZ54 |